Avalon GloboCare
ALBT
ALBT was delisted on the 21st of July, 2026.
15 hedge funds and large institutions have $5.86M invested in Avalon GloboCare in 2019 Q1 according to their latest regulatory filings, with 15 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
17,653% more capital invested
Capital invested by funds: $33K → $5.86M (+$5.83M)
1,400% more funds holding
Funds holding: 1 → 15 (+14)
1,400% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 1
0.01% more ownership
Funds ownership: 0% → 0.01% (+0.01%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.5M |
| 2 |
Millennium Management
New York
|
+$945K |
| 3 |
Goldman Sachs
New York
|
+$357K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$316K |
| 5 |
TEE
Tibra Equities Europe
London,
United Kingdom
|
+$177K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Centiva Capital
New York
|
-$33K |
ALBT Hedge Fund Activity: Q1 2019 in Review
15 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Avalon GloboCare (ALBT) for Q1 2019, worth a combined $5.86M — up 17,653% from $33K a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new ALBT positions and 1 closed out — a net gain of 14 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Vanguard Group, opening a new position worth an estimated $2.5M. The largest seller was Centiva Capital, exiting entirely with an estimated $33K sold.
- 15 institutional investors held Avalon GloboCare (ALBT) as of Q1 2019, up from 1 in Q4 2018.
- Funds reported $5.86M of Avalon GloboCare stock for Q1 2019, up 17,653% quarter-over-quarter.
- 15 funds opened new Avalon GloboCare positions in Q1 2019 and 1 closed out, a net change of +14 holders.
- The largest Avalon GloboCare buyer in Q1 2019 was Vanguard Group, an estimated $2.5M added.
- The largest Avalon GloboCare seller in Q1 2019 was Centiva Capital, an estimated $33K sold.
Based on aggregated 13F filings for Q1 2019.